Newsroom
Sorted by: Latest
-
DEFINITIVE Trial Reaches Major Milestone: All Centres Approved and More Than 50% Recruitment Achieved
BARCELONA, Spain--(BUSINESS WIRE)--The DEFINITIVE project, a landmark European Union-funded international phase III clinical trial evaluating the use of the HER2DX diagnostic assay to guide personalised treatment in early-stage HER2-positive breast cancer (BC), announces two major operational milestones at the ESMO Breast Cancer 2026 congress. Approvals have been obtained in the 7 participating countries, 33 clinicals sites are now open for patient recruitment. The trial has reached over 50% of...
-
ProFrac Holding Corp. Reports First Quarter 2026 Results
WILLOW PARK, Texas--(BUSINESS WIRE)--ProFrac Holding Corp. (NASDAQ: ACDC) (“ProFrac”, or the “Company”) today announced financial and operational results for its 2026 first quarter ended March 31, 2026. First Quarter 2026 Results Total revenue was $450 million compared to fourth quarter revenue of $437 million Net loss was $81 million compared to net loss of $141 million in the fourth quarter Adjusted EBITDA¹ was $54 million compared to $61 million in the fourth quarter; 12% of revenue in the f...
-
Swedbank Robur Fonder AB UK Regulatory Announcement: Form 8.3
STOCKHOLM--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Swedbank Robur Fonder AB (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be na...
-
Drug Farm to Present Ophthalmologic and CNS Findings from Phase 1b Study of First-in-Class ALPK1 Inhibitor DF-003 in ROSAH Syndrome at ARVO 2026
ALBANY, N.Y. & SHANGHAI--(BUSINESS WIRE)--Drug Farm today announced ophthalmologic and central nervous system (CNS) findings from its Phase 1b study of DF-003, a first-in-class oral ALPK1 inhibitor, will be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2026 annual meeting in Denver, CO. The presentation will highlight early evidence of improvements in visual function, optic nerve pathology, and neurological symptoms in patients with ROSAH syndrome, a rare genetic...
-
Indonesia–China Launch Cross-Border Payments Connectivity, Connecting Millions of Merchants via Ant International’s Alipay+
SINGAPORE--(BUSINESS WIRE)--Under the guidance of Bank Indonesia and People's Bank of China, the China-Indonesia cross-border QR payment linkage was launched between Indonesia’s Quick Response Code Indonesian Standard (QRIS) and China’s leading payment ecosystems, enabled by Alipay+, the unified wallet gateway of Ant International, and UnionPay International. A milestone in regional connectivity, the initiative opens a new bridge for commerce between the 1.4 billion Chinese people and the 280-m...
-
Six Flags Announces Leadership Transitions
CHARLOTTE, N.C.--(BUSINESS WIRE)--SIX FLAGS ANNOUNCES LEADERSHIP TRANSITIONS...
-
Renesas Completes Acquisition of Irida Labs to Expand Vision AI Software Capabilities and Accelerates System-Level Vision Solutions
TOKYO--(BUSINESS WIRE)--Renesas has completed the acquisition of Irida Labs, strengthening its Vision AI software and accelerating system-level vision solutions....
-
William Blair Accelerates Investment in Biotech Equity Research and Equities Platform
CHICAGO & NEW YORK--(BUSINESS WIRE)--William Blair today announced a strategic investment in its equities platform, expanding resources across biotech equity research and institutional sales and trading to support long-term client demand driven by sustained innovation and increasingly complex institutional strategies. Alethia Young Joins Biotech Equity Research, Expanding Biotech Coverage Alethia Young has joined William Blair’s Biotech Equity Research team, reflecting the firm’s strategic inve...
-
Six Flags Entertainment Corporation Reports 2026 First Quarter Results
CHARLOTTE, N.C.--(BUSINESS WIRE)--Six Flags Entertainment Corporation (NYSE: FUN), the largest regional amusement park operator in North America, today announced its results for the first quarter ended March 29, 2026. First Quarter 2026 Results As compared to the first quarter of 2025: Net revenues increased 12% to $225.6 million. Attendance increased 4% to 2.9 million visits. Per capita spending(1) increased 6% to $69.26, reflecting effective ticket pricing initiatives, improved ticket mix, an...
-
Ooma Launches Small Business Spotlight Award to Recognize the Entrepreneurs Powering Local Communities
SUNNYVALE, Calif.--(BUSINESS WIRE)--In recognition of National Small Business Month, which celebrates the critical role small businesses play in driving the U.S. economy and supporting local communities, Ooma, Inc., a provider of advanced communications services for businesses and consumers, today announced the launch of its inaugural Ooma Small Business Spotlight Award, a new program designed to recognize and elevate the stories of small businesses across the country. At a time when many small...